Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
AlphaCentric Advisors LLC (CIK 1913464) reported $100.1M across 250 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: GILD ($2.8M, 2.82%), RPV ($2.6M, 2.56%), IWD ($2.5M, 2.52%), AZNCF ($2.2M, 2.21%), VRTX ($2.2M, 2.20%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | GILD | GILEAD SCIENCES INC | $2.8M | 2.82% | 20,260 | Trimmed |
| 2 | RPV | INVESCO EXCHANGE TRADED FD T | $2.6M | 2.56% | 23,882 | Added |
| 3 | IWD | ISHARES TR | $2.5M | 2.52% | 11,825 | Added |
| 4 | AZNCF | ASTRAZENECA PLC | $2.2M | 2.21% | 11,232 | New |
| 5 | VRTX | VERTEX PHARMACEUTICALS INC | $2.2M | 2.20% | 4,931 | Added |
| 6 | EEFT | EURONET WORLDWIDE INC | $1.8M | 1.85% | 27,855 | Hold |
| 7 | INVH | INVITATION HOMES INC | $1.8M | 1.81% | 73,000 | Trimmed |
| 8 | IONS | IONIS PHARMACEUTICALS INC | $1.5M | 1.47% | 19,587 | Added |
| 9 | INSM | INSMED INC | $1.5M | 1.45% | 8,874 | Added |
| 10 | INCY | INCYTE CORP | $1.3M | 1.34% | 14,245 | Added |
| 11 | ROIV | ROIVANT SCIENCES LTD | $1.3M | 1.32% | 47,667 | Added |
| 12 | ARGX | ARGENX SE | $1.3M | 1.31% | 1,794 | Added |
| 13 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.3M | 1.26% | 9,607 | Added |
| 14 | AXR | AMREP CORP | $1.3M | 1.25% | 44,496 | Trimmed |
| 15 | BFS | SAUL CTRS INC | $1.1M | 1.14% | 35,000 | Added |
| 16 | STXS | STEREOTAXIS INC | $1.1M | 1.10% | 600,000 | Hold |
| 17 | AXSM | AXSOME THERAPEUTICS INC. | $1.1M | 1.09% | 6,438 | Added |
| 18 | ASND | ASCENDIS PHARMA A/S | $1.0M | 1.03% | 4,526 | Added |
| 19 | AMPX | AMPRIUS TECHNOLOGIES INC | $1.0M | 1.01% | 60,000 | Added |
| 20 | BHR/PRD | BRAEMAR HOTELS & RESORTS INC | $985,000 | 0.98% | 1.0M | Hold |
| 21 | APGE | APOGEE THERAPEUTICS INC | $956,929 | 0.96% | 11,369 | Added |
| 22 | PTGX | PROTAGONIST THERAPEUTICS INC | $952,816 | 0.95% | 9,040 | Added |
| 23 | CTO | CTO RLTY GROWTH INC NEW | $931,896 | 0.93% | 50,400 | Added |
| 24 | SMA | SMARTSTOP SELF STORAG REIT I | $908,400 | 0.91% | 30,000 | Added |
| 25 | AMGN | AMGEN INC | $819,459 | 0.82% | 2,329 | Added |
Source: SEC Form 13F filings · as of 2026-03-31